CoChat

Varespladib

&NA; · 2011 · American Journal Cardiovascular Drugs

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

Anthera Pharmaceuticals is developing an oral formulation of varespladib (A 001; A 002; A-001; A-002; LY 315920; LY 333013; LY315920; LY333013; S 3013; S 5920; S-3013; S-5920; Varespladib methyl) for once-daily treatment of acute coronary syndromes. Varespladib acts by inhibiting secretory phospholipase A2 (sPLA2) and the drug is currently being evaluated in approximately 6500 patients with acute coronary syndromes receiving atorvastatin in the placebo-controlled VISTA 16 (NCT01130246) trial being conducted in North America and Europe. This review discusses the development history and scientific profile of this new compound.

Overview

Integrity signals

Registry

Crossref · 10.2165/11533650-000000000-00000

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 4 references

Research works printed but not linked: 2

  1. Parnham, 1996 Dec, Drug News and Perspective, 9, 631
  2. Kearney, 1999, Mediators of Inflammation, 8, 8

Cited by

See all 38

Metadata

Authors
&NA;
Corresponding author
&NA;
Venue
American Journal Cardiovascular Drugs
Published
2011-04
Volume
11
Issue
2
Pages
137-143
ISSN
1175-3277 (ISSN-L)
OpenAlex
W4241977973
Cited by
38
References
4
Citations by year
2026: 5 · 2024: 1 · 2023: 3 · 2022: 7 · 2021: 6 · 2020: 9 · 2019: 2 · 2018: 3 · 2016: 1 · 2015: 1
Type
other
Language
en
Open access
closed
Locations
  • American Journal of Cardiovascular Drugs (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Antiplatelet Therapy and Cardiovascular Diseases
  • Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
Keywords
varespladib, acute coronary syndrome, oral dosage forms, atorvastatin, drug development history
MeSH terms
Acetates, Animals, Clinical Trials as Topic, Humans, Indoles, Keto Acids, Acute Coronary Syndrome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Varespladib. https://app.cochat.ai/papers/10.2165/11533650-000000000-00000
The paper
&NA;. (2011). Varespladib. American Journal Cardiovascular Drugs. https://doi.org/10.2165/11533650-000000000-00000

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.